Hyperdiploid karyotype in a child with hypocellular primary myelodysplastic syndrome

European Journal of Haematology

Volumn 71, Issue 5, 2003, Pages 399-401

  De Souza Fernandez, Teresa ^a,b   Ornellas, Maria Helena ^a,b   De Cássia Tavares, Rita ^a   Otero, Luize ^a   Diamond, Hilda Rachel ^a   Bouzas, Luis Fernando ^a   Tabak, Daniel ^a   Abdelhay, Eliana ^c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL STRUCTURE; CYTOGENETICS; DIPLOIDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ANEUPLOIDY; BONE MARROW TRANSPLANTATION; CLONE CELLS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; MYELODYSPLASTIC SYNDROMES;

EID: 0142217316     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00150.x     Document Type: Letter

References (17)

1. SASAKI H, MANABE A, KOJIMA S, et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001;15:1713-1720.
2. HASLE H, NIEMEYER CM, CHESSELLS JM, BAUMANN I, BENNETT JM, KERNDRUP G, HEAD DR. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282.
3. ISCN. An International System for Human Cytogenetic Nomenclature. Mitelman F, ed. Basel: S Karger, 1995.
4. STETLER-STEVENSON M, ARTHUR DC, JABBOUR N, XIE, XY, MOLLDREM J, BARRET AJ, VENZON D, RICK ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-987.
5. ACAR H, ÇALISKAN Ü, KAYNAK M, YILDIRIM MSW, LARGAESPADA DA. Hyperdiploid karyotype in a childhood MDS patient. Clin Lab Haem 2001;23:255-258.
6. CULLIGAN DJ, BOWEN DT, MAY A, WHITE D, PADUA RA. Refractory anaemia with preleukaemic polyclonal haemopoiesis and the emergence of monoclonal erythropoiesis on disease progression. Br J Haematol 1995;89:675-677.
7. APPELBAUM FR, BARRAL J, STORB R, RAMBERG R, DONEY K, SALE GE, THOMAS ED. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol 1987;15:1134-1139.
8. MARTINEZ-JARAMILLO G, FLORES-FIGUEROA E, SANCHEZ-VALLE E, GUTIÉRREZ-ESPÍNOLA G, GÓMEZ-MORALES E, MONTESINOS JJ, FLORES-GUZMÁN, CHÁVEZ-GONZÁLES A, ALVARADO-MORENO JA, MAYANI H. Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia. Leuk Res 2002;26:955-963.
9. KEUNG YK, PETTENATI MJ, CRUZ JM, POWELL BL, WOODRUFF RD, BUSS DH. Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol 2001;66:167-171.
10. MAYNADIÉ M, PICARD F, HUSSON B et al. and the Groupe d'Étude Immunologique des Leucémies (GEIL). Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002;100:2349-2356.
11. BACIGALUPO A, BRUNO B, SARACCO P et al. Antilymphocytic globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 2000;95:1931-1934.
12. KOJIMA S, OHARA A, TSUCHIDA M, KUDOH T, HANADA R, OKIMOTO Y, KANEKO T, TANAKO T, IKUTA K, TSUKIMOTO I. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002;100:786-790.
13. HELLSTROM-LINDBERG E, KANTER-LEWENSOHN L, OST A. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erytropoietin. Leuk Res 1997;21:415-425.
14. TOMONAGA M, NAGAI K. Hypocellular Myelodysplastic Syndromes and Hypocellular Acute Myeloid Leukemia: Relationship to Aplastic Anemia. In BENNETT JM, ed. The Myelodysplastic Syndromes. Pathobiology and Clinical Management. New York: Marcel Dekker, 2002:121-138.
15. PUI CH. Childhood leukemias. N Engl J Med 1995;332:1618-1630.
16. DOUGLAS EC, LOOK AT, WEBBER B, PARHAM D, WILIMAS JA, GREEN AA, ROBERSON PK. Hyperdiploidy and chromosomal rearrangements define the aplastic variant of Wilm's tumor. J Clin Oncol 1986;4:975-981.
17. SUTTON L, CHASTANG C, RIBAUD P, et al. for the Societé Française de Greffe de Moelle. Factors influencing outcome in de novo Myelodysplastic Syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients. Blood 1996;88:358-365.